Mark Leong

Executive Chairman (ACCA, ISCA, SID)

Mr Leong is a Fellow of the Association of Chartered Certified Accountants (ACCA), Chartered Accountant of the Institute of Singapore Chartered Accountants (ISCA) and Member of the Singapore Institute of Directors (SID).

An Australian Permanent Resident with prior ASX board experience, Mr Leong has more than 22 years of corporate, management and directorship experience in a broad range of functions in a diverse range of industries having undertaken several C-suite roles (CEO, COO, & CFO) in several private as well as listed companies and presently serves as Independent Director in 3 Singapore listed companies.

Vlado Bosanac

Non-Executive Senior Independent Director

Mr Bosanac combines over 30 years’ experience in capital markets, deal origination, negotiation, corporate advisory, strategy, project implementation, leveraged and management buy-outs, as well as private and public investment. Over the past 20 years he has focussed on bio-medical, medical device and pharmaceutical development.

Over his career, Mr Bosanac has contributed towards several listing and liquidity events for numerous companies. In June this year, he was appointed to the Board of soon to be listed Singapore based Clean Mining Technologies Limited.

Mr Bosanac joins the board of OSX with extensive ASX experience as Chairman and CEO of ASX listed Advanced Human Imaging Limited (ASX: AHI). In addition, in November 2021, Mr. Bosanac successfully dual listed AHI on the NASDAQ Exchange in the USA.

Professor Teoh Swee Hin

Non-Executive Director (B Eng (1st Hons), PhD Materials Engineering (Singapore))

Prof Teoh Swee Hin, is the President's Chair, School of Chemical and Biomedical Engineering (SCBE). He holds a joint appointment with the Lee Kong Chian School of Medicine (LKC Med) at Nanyang Technological University. His contribution is in the development and clinical translation of 3D bioresorbable scaffolds. Majoring in Materials Engineering (B. Eng -1st Class Hon and PhD, Monash University), his research journey focused at translating the materials research to biomedical benefits. He is a Fellow of the Academy of Engineers Singapore and Chief Engineer at Skin Research Institute of Singapore. His research focused on the study of mechanisms that promote cells proliferation and differentiation as a result of mechno induction through load bearing scaffolds for tissue regeneration and remodelling.

BProf Teoh's pioneering work on 3D printed scaffold led to him receiving the prestigious "Golden Innovation Award" at the Far East Economic Review, and the Institute of Engineers "Prestigious Engineering Achievement Award" in 2004. His group was ranked 1st in bone tissue engineering scaffolds in World Web of Science 2010. He was honoured with the Special Award for "Scientific Life-Time Achievement in Bone Tissue Engineering" at Bone-Tec 2015, Stuttgart. As a part of SG50 celebrations, he was featured as one of Singapore's profiled scientists in the book titled "Singapore's Scientific Pioneers".

Professor Teoh is presently the Chairman, Singapore Academy, Asia Regulatory Professional Association (ARPA). He sits in as board of editors Tissue Engineering, Journal of Tissue Engineering and Regenerative Medicine, Journal of Mechanical Behaviour of Biomedical Materials, Journal of Oral & Maxillofacial Research and Proceedings of the Institution of Mechanical Engineers Part H: Journal of Engineering in Medicine.

Daniel Ow

Non-Executive Director (B.Com, C.A (Aust))

Mr Ow has over twenty years of international experience across multiple industries, including infrastructure, resources, property and fast-moving consumer goods. Mr Ow has held several accounting and management roles with large multinational corporations and is a Certified Practising Accountant (CPA), Australia. He is currently Manager Financial Business Partners at Perth Airport. Along with professional experience in investor relations, he also served as Trustee Director on the Rio Tinto Staff Superannuation Fund (now merged with Equip Super).

Goh Khoon Seng

Chief Executive Officer (M.Eng (Mech) (Singapore))

Mr Goh's 30-year career spans both start-ups and global multinational corporations, with responsibilities in research & development, manufacturing, regional sales and marketing, and country management. Prior to joining Osteopore Mr Goh spent over 20 years with Medtronic plc (Medtronic plc is the world's largest medical device company) and Edwards Lifesciences Asia in various senior management roles.

Mr Goh has been a Director of Osteopore Pte Ltd, since 2015 and has been involved in all aspects of the Company.

Mr Goh holds a Masters in Engineering (National University of Singapore) and post graduate diploma with Chartered Institute of Marketing (UK).

Lim Jing

Chief Technology Officer (Ph.D. (Singapore))

Dr. Lim holds a PhD from Nanyang Technological University, Singapore. Prior to joining Osteopore, Dr. Lim conducted research on biomaterials for tissue engineering and regenerative medicine, and developed material fabrication platforms. Dr. Lim published 14 articles in internationally peer-reviewed journals in that time. Dr. Lim joined Osteopore in December 2014, and has led Osteopore to important regulatory and quality milestones. In addition, Dr. Lim led the expansion of product and therapy portfolio, and contributed to the improvement in manufacturing efficiency.

Carl Runde

Chief Financial Officer (BA (Hon), MBA, PhD)

Carl Runde has over 20 years of international experience as a finance business partner in the medical device industry. Before joining Osteopore, he held the position of Vice President, Global Financial Planning & Analysis at ResMed (NYSE: RMD, ASX: RMD) having held the positions of VP Finance, Global R&D and Regional Financial Controller, ResMed Asia Pacific.

Dr Runde began his career in the medical device industry with MAP GmbH in Munich (1998) as a Financial Planning and Reporting Manager and subsequently as MAP Group Financial Controller. Prior to medical devices, he held finance and accounting positions in the hospitality industry with Käfer GmbH & Co KG and with the Hilton International Hotel Group.

Dr Runde holds a Bachelor of Arts (Honours) in international relations from the University of the Witwatersrand, a Master of Business Administration from Macquarie University and a PhD in Business from the University of Sydney.